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Abstract
Background: Gene expression patterns provide a detailed view of cellular functions. Comparison
of profiles in disease vs normal conditions provides insights into the processes underlying disease
progression. However, availability and integration of public gene expression datasets remains a
major challenge. The aim of the present study was to explore the transcriptome of pancreatic islets
and, based on this information, to prepare a comprehensive and open access inventory of insulin-
producing beta cell gene expression, the Beta Cell Gene Atlas (BCGA).
Methods:  We performed Massively Parallel Signature Sequencing (MPSS) analysis of human
pancreatic islet samples and microarray analyses of purified rat beta cells, alpha cells and INS-1 cells,
and compared the information with available array data in the literature.
Results: MPSS analysis detected around 7600 mRNA transcripts, of which around a third were of
low abundance. We identified 2000 and 1400 transcripts that are enriched/depleted in beta cells
compared to alpha cells and INS-1 cells, respectively. Microarray analysis identified around 200
transcription factors that are differentially expressed in either beta or alpha cells. We reanalyzed
publicly available gene expression data and integrated these results with the new data from this
study to build the BCGA. The BCGA contains basal (untreated conditions) gene expression level
estimates in beta cells as well as in different cell types in human, rat and mouse pancreas.
Hierarchical clustering of expression profile estimates classify cell types based on species while beta
cells were clustered together.
Conclusion: Our gene atlas is a valuable source for detailed information on the gene expression
distribution in beta cells and pancreatic islets along with insulin producing cell lines. The BCGA tool,
as well as the data and code used to generate the Atlas are available at the T1Dbase website
(T1DBase.org).
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Background
The pancreas is composed of two types of tissue: exocrine
and endocrine. The exocrine pancreas is made of acinar
cells and secretes digestive enzymes into a network of
ducts, while the endocrine pancreas consists of the islets
of Langerhans and secretes hormones into the blood-
stream. Pancreatic β cells are highly specialized cells
within the islets of Langerhans responsible for producing
vast amounts of insulin in response to changing glucose
levels in blood. β cells are affected during Type-1 Diabetes
(T1D) and Type-2 Diabetes (T2D) and are a major focal
point of researchers in both fields. Availability of a com-
plete list of transcripts expressed in human β cells, along
with the transcriptomes of other cell types in endocrine
and exocrine pancreas will aid T1D and T2D research.
Microarray technology is presently the preferred method
for global (comprehensive) gene expression measurement
and has been applied successfully to pancreatic islet and β
cell-focused studies from human, mouse and rat [1-4].
MPSS is an alternative technology that estimates gene
expression by counting short sequence signatures gener-
ated from up to one million expressed sequences per run.
MPSS analyses provide very deep transcriptome analyses
of individual tissues or cell types [5]. Unlike microarrays,
MPSS eliminates the need to predefine genes that can be
detected and samples the transcriptome deeply enough to
detect transcripts expressed at levels as low as three copies
per cell [6].
Systems biology is a multi-disciplinary science that seeks
to quantify the molecular elements of a biological system,
determine their interactions, integrate these data into
molecular network models and then correlate network
dynamics (changes in the components and architecture of
the network) with developmental, physiological and
pathological behaviors [7]. Such dynamic models serve to
generate predictive hypotheses that can be experimentally
verified. A first step toward constructing a systems biology
network model is to build a comprehensive quantitative
expressed-mRNA database reflecting dynamically chang-
ing transcriptomes of the cell types of interest (at different
stages of their development, functional operation or dis-
ease progression). There are two types of dynamic molec-
ular networks that in practice are closely integrated:
protein and gene regulatory networks. Protein networks
(protein/protein/small molecule interactions), for exam-
ple, transmit information from the cell surface to the
nucleus, mediate metabolism and provide the cell with
structural integrity. On the other hand, gene regulatory
networks integrate/modulate information and control
behavior of protein networks or complex molecular
machines through the action of transcription factors.
Hence, delineation of the expression patterns of transcrip-
tion factors of a particular cell type provides the compo-
nents of its gene regulatory networks and initial insights
into the networks that mediate its functional regulation.
Specific changes observed in these networks under dis-
eased states might serve as biomarkers of disease progres-
sion. Moreover, specific expression patterns, static or
temporal, of a gene can provide important clues to its
physiological function.
Current efforts to catalog gene expression in tissues lack
detailed information about pancreas and pancreatic islets.
Symatlas, the most widely used database of tissue expres-
sion, contains human and mouse expression data from up
to 79 tissues under basal conditions [8]. In Symatlas, pan-
creas is represented as only one column without disclos-
ing differences at the cellular level. The same is true for
other complex tissues, such as liver and lung. Nor is an
effort made to compare differences and commonalities
between the same tissue in human and mouse. Having
more detailed atlases that attempt to represent informa-
tion from multicellular organs across different species and
different data types is warranted.
There are several technical challenges that preclude
obtaining of pure human β cells. These include limited
availability of human material, no established protocol to
isolate β cells from human pancreatic islets and the lack of
human beta cell lines. In order to obtain a relatively com-
plete β cell gene expression profile, we performed MPSS
analysis of two independent human islet samples. Human
islets contain α and β cells in a ratio between 0.3–0.5 to 1
and make up approximately 80% of the whole cell popu-
lation, that are difficult to separate in human samples.
Accordingly, we also characterized by microarray analysis
rat β and α cells that are readily separated by FACS. The
assumption is that the islet-cell transcriptomes will be
similar in human and rat (and mouse). We also per-
formed microarray analyses on the rat INS-1E cells, a glu-
cose-responsive insulinoma cell line commonly used as a
model to study β cell biology. We combined these four
new types of data with expression data from the literature
and public databases on pancreas and insulin-producing
cells. The resulting 'β Cell Gene Atlas' (BCGA) incorpo-
rates basal gene expression data from experiments per-
formed with pancreatic β and other cells in human, rat
and mouse. The data assembled in the BCGA provide a
major resource contribution to our understanding of β
cells and the expression landscapes of cells in the pancreas
that will benefit efforts to understand and ultimately pre-
vent diabetes.
Methods
Cell culture
Human pancreatic islets from two healthy donors were
cultured for 48 h in complete RPMI medium [9]. (Donor
1: 45 years old female, BMI 25.7, Blood Group A; DonorBMC Medical Genomics 2009, 2:3 http://www.biomedcentral.com/1755-8794/2/3
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2: 69 year old male, BMI 24.7, Blood Group O). Human
islets used were of excellent quality: β cell percentages of
the two donors were 53 and 59%. Insulin release stimula-
tion indices (16.7 vs 1.67 mM glucose) were 8.9 and 10.4.
β cell percentage analysis and insulin release determina-
tion were performed as described [10]. INS-1 cells were
cultured in complete medium and collected for analysis
after 48 h [11]. Primary rat β cells (>87% β cells) and non-
β cells (<3% beta cells, mostly α) were isolated by FACS
mediated purification of two different rat islet prepara-
tions [12]. Total RNA was isolated using either column
based (Qiagen RNEasy) or a Trizol-based method
(UltraSpec). Insulin and glucagon-positive cell percent-
ages were estimated by immuno-histochemical staining.
Human islet study was approved by the Institutional
Review Board (exempt no #4). Rat samples were prepared
following the guidelines of the Belgian Regulations for
Animal Care.
Massively Parallel Signature Sequencing Analysis
mRNA was processed according to the MPSS (Solexa, CA)
protocol as described [5]. MPSS procedure creates 17 bp
signatures of the transcripts. The abundance of each signa-
ture was converted to transcripts per million (tpm) for
purpose of comparison between samples. Each signature
was aligned to the current human genome (UCSC hg18)
and coding sequences (RefSeq, mRNA, and EST) by mod-
ified BLAT analysis to detect short sequence alignments
[13]. In case a gene was represented by more than one sig-
nature, their tpm values were added to obtain a final tpm
count for that gene.
Microarray analysis
Low-level processing, normalization and statistical analy-
sis of microarrays were performed using R/Bioconductor
packages (Release 2.1) [14]. MAS5 algorithm was selected
as the method of normalization with target intensity set to
1500. Differential expression analysis was assessed by lin-
ear models and empirical Bayes moderated F statistics
within the Limma R package [15]. Biological Process GO
terms for each gene were obtained from Bioconductor
Project metadata packages and 'GOstats' package was used
to calculate the enrichment of GO terms [16]. All datasets
can be accessed at NCBI-GEO repository (GSE13381).
Downloaded Datasets
Microarray expression datasets were downloaded from
public databases [see Additional File 1] in raw form (if
available), and were reanalyzed, reannotated, and inte-
grated with the new data generated here. The datasets we
downloaded were generated from the following sources:
1. Human: laser capture microdissected β cells, pancreatic
islets, exocrine pancreas, ductal cells, 2. Mouse: islets,
whole pancreas, MIN6 cell lines, 3. Rat: FACS-purified β
cells, α cells (non-β cells from FACS isolation), islets and
whole pancreas.
Homology Analysis and Expression Data Integration for 
BCGA
Homologs of human, rat, and mouse genes were obtained
from several sources: HomoloGene [17], Mouse Genome
Database [18], Rat Genome Database [19], Ensembl [20],
Inparanoid [21], OrthoMCL [22] and KEGG [23]. The
data sources were used in the order listed here and all con-
sistent orthology information was added to the homology
database. No attempt was made to weight information
based on the number of sources reporting the information
because many of the sources are not independent.
Expression signal intensity values in each array were con-
verted to ranks within the experiments; the highest value
was used for genes represented by more than one probe.
The rank values of genes in a given cell type were averaged
with other calculated values from experiments performed
with the same cell type. We observed that probe signal
intensities are bimodal distributed and genes with
Affymetrix absence and presence calls belong to the pop-
ulation with lower and higher means, respectively. There-
fore, we performed model based clustering and calculated
for each gene the probability of belonging to the group of
present genes [24]. A final probability score of expression
for each gene was calculated by combining probabilities
using Fisher's method [25].
Results
MPSS expression data analysis
1,051,000 and 1,313,239 signatures were sequenced,
respectively, in the first and second MPSS islet libraries.
The distribution of the raw signatures, i.e. before they are
mapped to specific genes, displays a skewed structure
towards low-copy transcripts, suggesting that the majority
of signatures fall in this category (Figure 1a). There were
11,946 unique signatures in islet sample 1 and 14,356 in
islet sample 2. When the transcriptomes were combined
there were 20,719 discrete sequences. The higher number
of signatures in islet sample 2 probably reflects, in part,
the greater depth of sequencing. The mean signature
counts were 121.7 and 109.4 tpm while the median
counts were 20 and 13 tpm. There was good correlation
between the two samples for complete observations
(Spearman 0.70) (Figure 1b). The existence of signatures
unique to each library is probably an indication of donor
variability that has been previously observed in large scale
studies of human islet transplantation [26].
In order to annotate raw signatures, we aligned each 17 bp
sequence to human genome or to ESTs and we deter-
mined Entrez Gene IDs that overlap with the genomic
regions [see Additional File 1]. This signature-to-geneBMC Medical Genomics 2009, 2:3 http://www.biomedcentral.com/1755-8794/2/3
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mapping was used to generate a gene-centric expression
set [see Additional File 2].
There were 5,080 different genes detected in sample 1 and
5,420 genes in sample 2 at a level of at least 5 tpm. The
two data sets generate 6,941 different genes, of which
3,552 are shared. We found 1196 unique signatures that
could be mapped to genomic regions that overlap with
coding sequences, but did not have any Entrez Gene IDs.
Table 1 lists the most abundant transcripts in the MPSS
result set. Insulin is at the top of the list with an average
level of 126,753 tpm, corresponding roughly to 13% of
the entire mRNA population in these human islet sam-
ples. Since our islet samples were composed of approxi-
mately 55–60% insulin-producing β cells, this data is in
line with previous estimates of insulin mRNA copy num-
bers in β cells, namely insulin constitutes about 30% of
the total mRNA [27]. Glucagon and somatostatin are also
A) Histogram of the signature counts in the raw MPSS dataset (before annotation) Figure 1
A) Histogram of the signature counts in the raw MPSS dataset (before annotation). The frequencies of signature 
logarithm 2 scale counts in both MPSS samples are plotted. B) Scatter plot of signature counts first islet sample (on x axis) vs 
second islet sample (on y axis). Tpm = transcripts per million.
Table 1: Expression of most enriched genes in the MPSS dataset
Gene id Symbols Description Islet1 Islet2 Average
3630 INS Insulin 115806 137701 126753
5068 REG3A Regenerating islet-derived 3 α 28372 46821 37596
57521 KIAA1303 Raptor 19447 51634 35540
5967 REG1A Regenerating islet-derived 1 α 44348 17588 30968
2641 GCG Glucagon 16163 37866 27014
5645 PRSS2 Protease, Serine, 2 35590 8946 22268
2778 GNAS GNAS complex locus 16287 27305 21796
6750 SST Somatostatin 22199 12592 17395
9568 GABBR2 Gamma-aminobutyric acid (GABA) B receptor, 2 20203 12561 16382
440387 CTRB2 Chymotrypsinogen B2 21726 5667 13696
653 BMP5 Bone morphogenetic protein 5 5759 8451 7105
23521 RPL13A Ribosomal protein L13a 6447 6452 6449
5968 REG1B Regenerating islet derived 1 β 9519 3176 6347
'Gene id' = Entrez Gene ids, 'Symbols' = HUGO names for each gene, 'Description' = detailed gene name, 'Islet1' = tpm counts in MPSS sample 
from islet 1, 'Islet2' = tpm counts in MPSS sample from islet 2, 'Average' = average tpm counts in MPSS sample in both samplesBMC Medical Genomics 2009, 2:3 http://www.biomedcentral.com/1755-8794/2/3
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in the list of highly expressed genes (30,845 and 17,395
tpm respectively, Table 1) which correspond with their
levels of 30% and 15% in the pancreatic islets.
In order to assess the functional processes associated with
the most abundant genes, we performed GO term enrich-
ment analysis. The top 200 transcripts are related to vari-
ous processes including protein biosynthesis, protein
metabolism, cellular biosynthesis and some stress
response related categories [see Additional File 3]. The
stress response processes probably originate from the
stress induced by islet isolation. On the other hand, bio-
logical processes related to regulation, transcription and
transcriptional activity are enriched among the 3591 tran-
scripts that are detected at levels lower than 25 tpm.
Indeed, most pancreatic islet specific transcription factors
are expressed at levels of 150 tpm or lower with the excep-
tion of PAX6 which is expressed at average 565 tpm (Table
2). This is consistent with a recent study of transcription
factor expression in adult human tissues indicating that
most are expressed below 20 copies per cell [28]. Domain-
based classification of transcription factors in the MPSS
dataset was performed using the list of 790 transcription
factors studied by Kong et al. [28] [see Additional File 4].
In the MPSS dataset, there are 243 transcription factors
expressed at a minimum average level of 5 tpm and 223 of
these could be classified into one of the 25 transcription
factor classes.
With the aim to assess whether transcripts reliably
detected by MPSS but not by microarrays were real, we
performed RT-PCR analysis of MAFA, SAA1, INCA1,
KCNIP3 and ZFXH2 genes in untreated control islets. We
also included as a positive control INS and NEUROD1 in
this analysis. Expression of all of the genes in the human
pancreatic islets was validated by RT-PCR assays [see Addi-
tional File 1].
Genes expressed in β cells, α cells and INS-1 cells
Currently, no established protocol exists for isolating
large amounts of viable, purified human β cells with min-
imum impact on gene expression. On the other hand,
methods are well established for isolation of β cells from
rat and mouse which does not interfere with normal tran-
scription patterns [29]. In order to estimate expression
levels of transcripts in human β cells, we took advantage
of the fact that 88% of the genes detected in these analyses
had direct human and rat orthologs. We compared our
MPSS data from human islets with microarray data from
2 independent samples of rat FACS-purified β cells, non-β
cells after β cell selection (mostly glucagon-positive α
cells), and 2 samples of insulin-producing INS-1 cell lines.
Purity of primary rat β cells was 87% and 89%, and the
rest of the cells were mainly α cells. The non-β cell sam-
ples consisted of 74.2% and 83% of glucagon-positive
cells, with less than 5% β cells (data not shown). The
results [see Additional File 5] indicate that there are 8783–
9696 genes expressed in rat β, α, and INS-1 cells (thresh-
old average signal intensity = 250, target intensity = 1500).
Differential expression analysis of genes expressed in rat β
vs rat non-β(mostly α) cells identified 960 genes that are
enriched in β cells (fold enrichment ≥ 2, FDR 2%). On the
other hand, there were 699 genes that were more highly
expressed in α cells compared to β cells (fold enrichment
≥ 2, FDR 2%). 4294 genes are shared between the two cell
types (fold change <2 and FDR >10%). Consistent with
this data, GO terms related to glycolysis pathway and car-
bohydrate metabolism are significantly enriched within
the group of genes highly expressed in rat beta cells (p <
0.01, hypergeometric test) [see Additional File 6]. There
were 346 and 312 transcription factors expressed in rat β
and α cells, respectively [see Additional File 4]. Some tran-
scription factors are expressed in only one cell type (qual-
itative differences), while some are expressed at different
levels (quantitative differences). There are 58 and 24 tran-
Table 2: Expression levels of select transcription factors in the MPSS dataset
Gene id Symbols Description Islet1 Islet2 Average
3110 HLXB9 Homeobox HB9 49 66 57
6927 HNF1 Transcription factor 1, hepatic 46 0 23
3170 HNF3 Forkhead box A2 63 232 147
6925 HNF4 Transcription factor 4 14 23 18
3175 HNF6 One cut domain, family member 1 6 3 4.5
3651 IPF1 Insulin promoter factor 1 38 48 43
3670 ISL1 ISL1 transcription factor, LIM/homeodomain 114 82 98
389692 MAFA v-maf oncogene homolog A 169 80 124
4760 NEUROD1 Neurogenic differentiation 1 12 66 39
4821 NKX2-2 NK2 transcription factor related, locus 2 205 36 120
4825 NKX6-1 NK6 transcription factor related, locus 1 67 90 78
5080 PAX6 Paired box gene 6 418 713 565
'Gene id' = Entrez Gene ids, 'Symbols' = HUGO names for each gene, 'Description' = detailed gene name, 'Islet1' = tpm counts in MPSS sample 
from islet 1, 'Islet2' = tpm counts in MPSS sample from islet 2, 'Average' = average tpm counts in MPSS sample in both samplesBMC Medical Genomics 2009, 2:3 http://www.biomedcentral.com/1755-8794/2/3
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scription factors expressed only in β and α cells, respec-
tively. In β cells, 41 transcription factors were expressed
higher than in α cells and 71 transcriptional regulators
were enriched in α cells.
With the aim of identifying α and β cell specific genes in
human, we compared the list of α and β cell-enriched
transcripts with a list of genes that contain human pancre-
atic islet-specific transcripts. The latter list was obtained by
comparing pancreatic islet MPSS data with a published
MPSS dataset of 32 human tissues [30]. A gene was called
80% or more specific to pancreatic islets if the signature
count in islets were equal or greater than 80% of the total
count of signatures across all tissues at a minimum level
of 20 tpm. There are 940 genes that are specific to pancre-
atic islets [see Additional File 7]. 324 out of these 940
genes are probably expressed mainly in β cells, as they are
expressed at higher levels (>= 1.5 fold) in rat β cells com-
pared to α cells [see Additional File 8]. Meanwhile, 119
genes are expressed only or higher than 1.5-fold in α cells
compared to β cells [see Additional File 8]. The overlap of
the pancreatic islet specific genes with genes expressed in
β cells includes known transcription factors, such as IPF1,
TCF1, NKX6-1 and NEUROD1, and genes such as
ALDOA, IGF2 and GLP1R.
Construction of β cell Gene Atlas
The task of finding out whether a gene is expressed prima-
rily in pancreatic β cells, islets or cell lines in different spe-
cies is very difficult and requires time consuming analysis
of diverse publications and/or re-analysis of available
microarray data. We have collected almost all available
public microarray data related to pancreas cells and from
that constructed the BCGA. The expression data comes
from 131 array analyses (mainly Affymetrix platform)
derived from 28 experiments, each performed with β cells,
α cells (current study), cell lines, islets, exocrine pancreas,
ductal cells or whole pancreas [see Additional File 1].
Expression estimates were obtained as outlined in the
Materials and Methods section.
The Atlas accepts any type of public transcript identifier
which may be entered directly or uploaded from a file.
The relative expression levels under basal conditions are
indicated by a grey-scale heatmap (Figure 2). The darker
cell colors indicate higher basal gene expression in the
cells. The view can be switched to two different views to
visualize the exact rank estimates with 95% confidence
intervals or a probability score of presence.
To obtain a high level comparison between different cell
types across three species, we performed hierarchical clus-
tering using all the gene expression values of different cell
types present in our Atlas. The integrated expression pro-
files were used to calculate a similarity matrix using Euc-
lidian distance metric. The dendogram was built by
average linkage clustering. This analysis roughly separates
the cells based on species (Figure 3). Human β cells and
mouse MIN6 cells (Table 2) are in the same branch as
other insulin producing cells. This suggests that insulin-
producing cells have similar profiles across three species.
There are approximately 120 distinct transcripts ubiqui-
tously expressed within the top 15% across all cell types
and species. This list includes basal cellular functions or
structure – such as 20 different ribosome subunits, several
actin gene isoforms, genes involved in protein translation
and structural proteins. These genes are likely candidates
to serve as internal controls in RT-PCR expression studies.
We then looked at the genes that are enriched in the pan-
creatic islets compared to the rest of the cells in the pan-
creas, including duct and exocrine pancreas cells. There
are 851 genes that fulfill such criteria. In order to assess
whether this list is supported by independent experi-
ments, we analyzed microarray data generated with two
different genetic mice models. First, we obtained the list of
genes that are significantly altered in TCF1/HNF1 knock-
out pancreas [31]. This perturbation leads to a progressive
reduction in β cell number, proliferation rate, and pancre-
atic insulin content. We compared the list of genes that are
decreased in TCF1 -/- pancreas compared to wild-type
pancreas with the list of islet-enriched genes. As expected,
this list has a significant overlap with the islet-enriched
genes (112 out of 851 genes, p = 4.0E-5, hypergeometric
test). As a negative control, we also inspected genes that
are increased in response to TCF1 perturbation; there was
no significant overlap with this group (p = 0.929). The
overlapping list includes NKX6-1, ARNT2, GAD1, GCK,
PCSK1 (PC1/PC3), and TMEM27. These genes have previ-
ously been determined to be either specific to pancreatic
β cells or to play a crucial in the functioning of β cells. We
performed a similar test with microarray data of AKR/J
mouse pancreas http://www.ncbi.nlm.nih.gov/projects/
geo/query/acc.cgi?acc=GSE10639. AKR/J mouse are resist-
ant to obesity when fed a high fat diet and the islet area
increases by 1.4 fold [32]. We performed analysis for sig-
nificance of overlap with the list of genes increased or
decreased in AKR/J mouse pancreas compared to B6 mice.
There was a significant overlap (p = 0.0166) of the islet-
enriched genes with the increased genes. We failed, how-
ever, to a find a significance of the overlap of decreased
genes (p = 0.1136). All together, these results suggest that
BCGA is reasonably successful in identifying genes
expressed in different parts of pancreas.
Discussion
We have used both MPSS and microarray data generated
in the current study, together with publicly available
expression data, to build a repository of β cell and pan-
creas gene expression, the β cell Gene Atlas (BCGA). TheBMC Medical Genomics 2009, 2:3 http://www.biomedcentral.com/1755-8794/2/3
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BCGA contains expression information for genes
expressed particularly in β cells and other cell types in
pancreas of humans, rats and mice. Obtaining a complete
list of genes expressed in a certain cell type is the first step
in generating a model of the biological networks that are
active under normal conditions but perturbed under dis-
ease. Therefore, the Atlas is an essential tool that will
allow application of systems biology to the field of pan-
creatic islet research and T1D research in particular.
BCGA can be queried with virtually any public identifier
(Gene symbols, Entrez Gene ids, ENSEMBL ids) from all
three species. Results are returned for all species that is
orthologous to the queried gene. BCGA is a resource that
allows side by side comparison of microarray data related
to pancreas with a special emphasis on pancreatic β cells.
BCGA will be useful in several research areas: β cell-spe-
cific biomarker discovery (as potential candidates for early
diagnosis, determining the stages of disease progression
and response to therapy), β cell regeneration (as a bench-
mark to compare regenerated islets) and pancreas devel-
opment projects (as a list of genes (or transcripts)
expressed in functional β (and α) cells encoding protein
molecular machines, protein interaction networks and
transcription factors encoding gene regulatory networks).
Microarrays are presently the standard method for global
gene expression studies. However, the list of genes repre-
sented on microarrays is based on a priori knowledge and
represents a subset of the whole genome. Compared to
microarrays, MPSS data has the advantage of being quan-
titative and permits comparison of transcript copies
between different datasets. MPSS analysis of two human
islet samples resulted in detection of around 7,600 tran-
scripts. These genes include many highly characterized
genes as well as genes whose functions in islets are
'β Cell Gene Atlas' results page Figure 2
'β Cell Gene Atlas' results page. If a gene is estimated to be present at a high level, it is denoted with a darker cell color. 
The intermediate abundances are indicated with lighter cell colors. Genes expressed with a probability score of 0.95 or higher 
are designated with a red border color. The results can be viewed either with by "species" or "tissue" groupings. The actual val-
ues used to draw the heatmap or the probability scores can be viewed with "gene rank" or "probability" view, respectively.BMC Medical Genomics 2009, 2:3 http://www.biomedcentral.com/1755-8794/2/3
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unknown. Results from microarray and MPSS platforms
agree to a certain extent, while there are some genes that
are only detected by one method. Similar moderate agree-
ment between the two platforms has been observed in
other studies [33,34]. MPSS technology is unable to detect
approximately 7% of known genes lacking a DpnII restric-
tion enzyme site [30]. The present MPSS data do not
include 630 genes that are detected in the upper 90th per-
centile levels in the human islet microarray data, which
contains around 130 genes that lack a DpnII site. There-
fore, this is not enough to explain the observed discrepan-
cies between the two technologies. Microarray probes may
have undesired properties, such as cross-hybridization,
that could lead to false positives that are not detected by
MPSS. The two methods have differential bias, including
those related to G+C content of gene sequences [35]. The
effect of G+C content on the stability of hybridized
sequences is well known, with higher G+C content corre-
sponding to more stable DNA duplexes in microarray
platform. On the other hand, the G+C content might
interfere with the sequencing properties in MPSS data.
Another possible source of error is the annotation of the
MPSS signatures. Around 20% of the signatures in our
islet dataset are mapped to more than one gene (i.e. the
signatures align to more than one location along the
human genome) and these were discarded from the anal-
ysis (Supplementary Information). There are also many
signatures not converted to genes. The results of Encyclo-
pedia of DNA Elements (ENCODE) project that focuses
on functional elements of 1% of the human genome, has
recently been published [36]. The majority (>60%) of
interrogated loci presented potential new exons mapping
in their introns, while two-thirds (68%) of the investi-
gated loci showed potential new putative TSS upstream of
their annotated first exon, often reaching into neighbor-
ing genes [36]. Current human genome annotations prob-
ably fail to determine these yet to be identified exons and
transcripts. Furthermore, some signatures (2209) could
not be aligned to the genome during our annotation proc-
ess. In subsequent analysis, approximately 1000 signa-
tures could be mapped to mitochondrial genome. We
have been able to align a subset of the unannotated signa-
tures to transcripts in NCBI Trace Archive database http://
www.ncbi.nlm.nih.gov/Traces/trace.cgi. These signatures
are probably from genes residing in regions that could not
be assembled to the rest of human genome. This might
indicate widespread existence of unknown exons and/or
genes that remain to be identified. Finally, polymor-
phisms probably contribute to the high number of tran-
scripts detected as present in the BCGA. The human islet
microarray data in the atlas originate from 20 different
individual samples and 9 experiments while the MPSS
data are derived from only two individuals.
The variability in the MPSS results (see Results) might be
explained by the differences in the depth of sequencing
(1.05 million vs 1.31 million signatures) and is in line
with previous observations of the variability between
individual donors [37]. It also could arise from cells being
at different stages of physiological response. One also
must note that there may be heterogeneity in the cell pop-
Hierarchical clustering of tissue expression profiles: The two  main branches of the group are β cells/cell lines and islets/ pancreas Figure 3
Hierarchical clustering of tissue expression profiles: 
The two main branches of the group are β cells/cell 
lines and islets/pancreas. h_beta: Human beta cells, 
m_min6: MIN6 cells, r_beta: rat beta cells, r_INS: INS-1 cells, 
r_panc: Rat pancreas, r_alpha: Rat alpha cells, r_isl: Rat islets, 
m_isl: Mouse islets, m_panc: mouse pancreas, h_duct: human 
ductal cells, h_isl: Human islets, h_exoc: Human exocrine 
cells.BMC Medical Genomics 2009, 2:3 http://www.biomedcentral.com/1755-8794/2/3
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ulations in the pancreas that the ratios of these different
cell types may differ in different human islet preparations.
Limited availability and prohibitively expensive cost of
MPSS precluded us from performing more MPSS experi-
ments. However, the cost of signature sequencing based
experiments (such as Solexa, ABI) has dropped dramati-
cally. We plan to carry out more experiments of this type
of next-gen sequencing and add to BCGA.
Transcription factors are essential for maintaining the
gene regulatory networks that regulate all cellular func-
tions: knowledge of regulatory behavior is key to predic-
tive models of biological systems [38]. In the present
study we have identified 346 and 312 transcription factors
that are expressed in rat β and α cells respectively. Tran-
scription factors with HLH, HD, bZip, NR and LIM
domains make up around 70% of the basally and differ-
entially expressed factors in rat β and α cells [see Addi-
tional File 4]. Complexity of bZip transcription factors
functioning is achieved through dimerization and high
throughput analysis of bZip-bZip interactions detected
200 preferential binding sites that regulate distinct genes
[39]. Atf-3 and binding partners Fos and Jun are enriched
in α cells while interacting partners Atf-6 and Xbp-1 are
enriched in β cells [see Additional File 4]. Atf-6 and Xbp-
1 are involved in initial stages of the unfolded protein
response and higher expression of these genes might be
indicative of a stronger unfolded protein response in β
cells compared to α cells, as suggested by previous studies
[40].
The quantitative nature of MPSS data and its digital count-
ing of individual mRNA transcripts allow direct compari-
son of these datasets without further normalization.
Comparison of MPSS expression in human islets to other
tissues indicates that 940 genes are expressed at >80% spe-
cificity in the pancreatic islet cells. 324 out of 940 islet spe-
cific genes are enriched in β cells compared to α cells.
Among these genes are well-known β cell-specific genes
such as PDX1, NEUROD1, IAPP, TCF1, NKX6-1 and ICA-
512 [see Additional File 7]. Massive β cell death takes
place during T1D and to a certain extent in T2D, raising
the possibility to search for β cell specific blood markers
secreted or released by β cell-specific genes. It is expected
that the levels of these β cell-specific blood proteins will
reflect the operation of the networks present in these cells,
which should allow us to distinguish between normal and
diseased β cells. Moreover, new blood proteins may be
released from β cells undergoing apoptosis thus providing
an indication of the extent of β cell destruction. Accord-
ingly, blood from healthy and recently diagnosed people
could be monitored to follow β cell mass and network
perturbation during disease progression. The results of the
present study, and the newly constructed BCGA, provide a
list of potential candidates for this novel approach.
It is worth mentioning that the information contained in
the BCGA is affected by the limitations inherent to micro-
array platforms and the algorithms utilized for homo-
logue detection. For example, there are currently no tools
in the BCGA to match genes belonging to the same family
across species. We expect to improve these aspects in the
future releases.
Conclusion
The BCGA is a repository that integrates high-throughput
gene expression datasets obtained in untreated β cells and
other cells of the pancreas. The available datasets include
the rat β and α cells microarray data performed in this
study, MPSS data from human pancreatic islets as well as
other publicly available dataset. BCGA contains gene
abundance estimates for each gene in different cell types
across three species. It is well known that gene networks
are dynamic and change during cell cycle and physiologi-
cal/pathophysiological responses. Our BCGA data pro-
vides an initial picture of the status of these networks and
levels of gene expression under basal conditions. These
data enable interesting comparisons between different
cells and cell lines in human, rat and mouse pancreas. Our
analysis using different models of β cell expansion or
reduction suggests that BCGA contains cell-specific data.
This information will be valuable for future studies
involving expression changes and dynamic processes. The
presently developed data pipeline is set up to incorporate
any new microarray data or other platforms, such as pro-
teomics, and to make it available to the research commu-
nity promptly on T1DBase. The atlas is available at
T1DBase http://T1DBase.org/page/AtlasHome, a bioin-
formatics resource for T1D researchers [41]. This cumula-
tive information, coupled to pathway analysis, will be of
great value for the ultimate understanding of gene/protein
networks regulating β cell development, function and
death.
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